Cargando…

Remimazolam’s Effects on Postoperative Nausea and Vomiting Are Similar to Those of Propofol after Laparoscopic Gynecological Surgery: A Randomized Controlled Trial

(1) Background: Remimazolam is a novel benzodiazepine that prevents postoperative nausea and vomiting (PONV), is more effective than volatile anesthetics, and was recently approved for use in Japan. (2) Methods: This prospective, double-blind, randomized controlled trial study aimed to compare the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Ayumu, Satomi, Shiho, Kakuta, Nami, Narasaki, Soshi, Toyota, Yukari, Miyoshi, Hirotsugu, Horikawa, Yousuke T., Saeki, Noboru, Tanaka, Katsuya, Tsutsumi, Yasuo M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455908/
https://www.ncbi.nlm.nih.gov/pubmed/37629444
http://dx.doi.org/10.3390/jcm12165402
_version_ 1785096565618114560
author Matsumoto, Ayumu
Satomi, Shiho
Kakuta, Nami
Narasaki, Soshi
Toyota, Yukari
Miyoshi, Hirotsugu
Horikawa, Yousuke T.
Saeki, Noboru
Tanaka, Katsuya
Tsutsumi, Yasuo M.
author_facet Matsumoto, Ayumu
Satomi, Shiho
Kakuta, Nami
Narasaki, Soshi
Toyota, Yukari
Miyoshi, Hirotsugu
Horikawa, Yousuke T.
Saeki, Noboru
Tanaka, Katsuya
Tsutsumi, Yasuo M.
author_sort Matsumoto, Ayumu
collection PubMed
description (1) Background: Remimazolam is a novel benzodiazepine that prevents postoperative nausea and vomiting (PONV), is more effective than volatile anesthetics, and was recently approved for use in Japan. (2) Methods: This prospective, double-blind, randomized controlled trial study aimed to compare the efficacy of remimazolam and propofol as general anesthetics in terms of the incidence of PONV after laparoscopic gynecological surgery (UMIN000046237). High-risk female patients who underwent general anesthesia with either remimazolam or propofol for the maintenance of anesthesia were enrolled. The primary outcome was the incidence of PONV in the two groups (i.e., REM versus PROP) 2 h and 24 h after surgery. The incidence of vomiting without nausea, rescue antiemetic use, and the severity of nausea were also evaluated. (3) Results: No significant differences in PONV were identified between the REM and PROP groups at 2 h or 24 h. Furthermore, no differences were observed in any of the measured parameters, and no adverse events were reported. (4) Conclusions: The results of the present study suggest that remimazolam may be as effective as propofol in preventing PONV; however, further investigation is necessary to identify possible differences between these two agents.
format Online
Article
Text
id pubmed-10455908
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104559082023-08-26 Remimazolam’s Effects on Postoperative Nausea and Vomiting Are Similar to Those of Propofol after Laparoscopic Gynecological Surgery: A Randomized Controlled Trial Matsumoto, Ayumu Satomi, Shiho Kakuta, Nami Narasaki, Soshi Toyota, Yukari Miyoshi, Hirotsugu Horikawa, Yousuke T. Saeki, Noboru Tanaka, Katsuya Tsutsumi, Yasuo M. J Clin Med Brief Report (1) Background: Remimazolam is a novel benzodiazepine that prevents postoperative nausea and vomiting (PONV), is more effective than volatile anesthetics, and was recently approved for use in Japan. (2) Methods: This prospective, double-blind, randomized controlled trial study aimed to compare the efficacy of remimazolam and propofol as general anesthetics in terms of the incidence of PONV after laparoscopic gynecological surgery (UMIN000046237). High-risk female patients who underwent general anesthesia with either remimazolam or propofol for the maintenance of anesthesia were enrolled. The primary outcome was the incidence of PONV in the two groups (i.e., REM versus PROP) 2 h and 24 h after surgery. The incidence of vomiting without nausea, rescue antiemetic use, and the severity of nausea were also evaluated. (3) Results: No significant differences in PONV were identified between the REM and PROP groups at 2 h or 24 h. Furthermore, no differences were observed in any of the measured parameters, and no adverse events were reported. (4) Conclusions: The results of the present study suggest that remimazolam may be as effective as propofol in preventing PONV; however, further investigation is necessary to identify possible differences between these two agents. MDPI 2023-08-20 /pmc/articles/PMC10455908/ /pubmed/37629444 http://dx.doi.org/10.3390/jcm12165402 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Matsumoto, Ayumu
Satomi, Shiho
Kakuta, Nami
Narasaki, Soshi
Toyota, Yukari
Miyoshi, Hirotsugu
Horikawa, Yousuke T.
Saeki, Noboru
Tanaka, Katsuya
Tsutsumi, Yasuo M.
Remimazolam’s Effects on Postoperative Nausea and Vomiting Are Similar to Those of Propofol after Laparoscopic Gynecological Surgery: A Randomized Controlled Trial
title Remimazolam’s Effects on Postoperative Nausea and Vomiting Are Similar to Those of Propofol after Laparoscopic Gynecological Surgery: A Randomized Controlled Trial
title_full Remimazolam’s Effects on Postoperative Nausea and Vomiting Are Similar to Those of Propofol after Laparoscopic Gynecological Surgery: A Randomized Controlled Trial
title_fullStr Remimazolam’s Effects on Postoperative Nausea and Vomiting Are Similar to Those of Propofol after Laparoscopic Gynecological Surgery: A Randomized Controlled Trial
title_full_unstemmed Remimazolam’s Effects on Postoperative Nausea and Vomiting Are Similar to Those of Propofol after Laparoscopic Gynecological Surgery: A Randomized Controlled Trial
title_short Remimazolam’s Effects on Postoperative Nausea and Vomiting Are Similar to Those of Propofol after Laparoscopic Gynecological Surgery: A Randomized Controlled Trial
title_sort remimazolam’s effects on postoperative nausea and vomiting are similar to those of propofol after laparoscopic gynecological surgery: a randomized controlled trial
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455908/
https://www.ncbi.nlm.nih.gov/pubmed/37629444
http://dx.doi.org/10.3390/jcm12165402
work_keys_str_mv AT matsumotoayumu remimazolamseffectsonpostoperativenauseaandvomitingaresimilartothoseofpropofolafterlaparoscopicgynecologicalsurgeryarandomizedcontrolledtrial
AT satomishiho remimazolamseffectsonpostoperativenauseaandvomitingaresimilartothoseofpropofolafterlaparoscopicgynecologicalsurgeryarandomizedcontrolledtrial
AT kakutanami remimazolamseffectsonpostoperativenauseaandvomitingaresimilartothoseofpropofolafterlaparoscopicgynecologicalsurgeryarandomizedcontrolledtrial
AT narasakisoshi remimazolamseffectsonpostoperativenauseaandvomitingaresimilartothoseofpropofolafterlaparoscopicgynecologicalsurgeryarandomizedcontrolledtrial
AT toyotayukari remimazolamseffectsonpostoperativenauseaandvomitingaresimilartothoseofpropofolafterlaparoscopicgynecologicalsurgeryarandomizedcontrolledtrial
AT miyoshihirotsugu remimazolamseffectsonpostoperativenauseaandvomitingaresimilartothoseofpropofolafterlaparoscopicgynecologicalsurgeryarandomizedcontrolledtrial
AT horikawayousuket remimazolamseffectsonpostoperativenauseaandvomitingaresimilartothoseofpropofolafterlaparoscopicgynecologicalsurgeryarandomizedcontrolledtrial
AT saekinoboru remimazolamseffectsonpostoperativenauseaandvomitingaresimilartothoseofpropofolafterlaparoscopicgynecologicalsurgeryarandomizedcontrolledtrial
AT tanakakatsuya remimazolamseffectsonpostoperativenauseaandvomitingaresimilartothoseofpropofolafterlaparoscopicgynecologicalsurgeryarandomizedcontrolledtrial
AT tsutsumiyasuom remimazolamseffectsonpostoperativenauseaandvomitingaresimilartothoseofpropofolafterlaparoscopicgynecologicalsurgeryarandomizedcontrolledtrial